Numerous studies investigating GLP-1-RAs have demonstrated their potential to interfere with the proliferation of different cancer types, including breast, prostate, ovarian, and pancreatic cancers [16,17]. This evidence concerns the gene GCG and familial pancreatic carcinoma.